ASCO 2023: New drug combination twice as effective for some ovarian cancer patients as next best treatment
A targeted drug combination for patients with a type of ovarian cancer could be nearly twice as…
A targeted drug combination for patients with a type of ovarian cancer could be nearly twice as…
A drug currently used to treat skin and lung cancers has been found to slow…
Peter Mac researchers have been awarded a four year grant from the Federal Government’s Medical…